心理社会敏度与血糖控制在儿童1型糖尿病诊所中的关联
Joseph Wardell1,2, Dana Albright3, Claire Chang4
1School of Public Health, University of Michigan, Ann Arbor, Michigan.
The science of diabetes self-management and care
|March 8, 2024
概括
患有1型糖尿病 (T1D) 的年轻人面临的心理社会挑战与较差的血糖控制有关. 早期识别和支持这些问题对于改善儿科糖尿病护理的健康结果至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 临床心理学 临床心理学
- 医疗保健中的社会工作
背景情况:
- 1型糖尿病 (T1D) 的管理需要在血糖控制的同时解决心理社会因素.
- 社会工作人员在儿童糖尿病诊所中在识别和管理社会心理风险方面发挥着至关重要的作用.
- 了解心理社会敏度和血糖水平之间的相互作用对于全面的T1D护理至关重要.
研究的目的:
- 确定1型糖尿病 (T1D) 的年轻人中心理社会风险的频率.
- 在这个人群中调查心理社会敏度和血糖水平之间的关联.
- 为临床实践提供有关儿童糖尿病护理中心理社会支持的信息.
主要方法:
- 对966名患有T1D的儿科患者 (1-26岁) 的临床数据进行了回顾性纵向分析.
- 包括诸如心理社会敏度,A1C (血糖控制) 和人口统计等变量.
- 统计分析包括千平方测试,威尔科克森等级总和测试和混合线性回归.
主要成果:
- 平均每年每位患者进行6.9次社会工作会议,评估每次访问的3个社会心理领域.
- 心理社会敏度的增加与降低血糖控制 (更高的A1C) 有显著的关联.
- 根据种族/种族,保险状况,年龄和心理社会敏度,A1C水平有很大的差异.
结论:
- 心理社会敏度是与真实世界儿科T1D人口的血糖控制相关的重要因素.
- 在诊所访问期间发现的心理社会问题的解决与降低血糖控制有关.
- 显然需要整合心理健康服务和儿童T1D患者的心理社会支持.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
534
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
534
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
Pathophysiology of Diabetes
928
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
928
Hypoglycemia and Glucagon
260
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260


